-
Medical journals
- Career
Internal Medicine - Issue 2/2014
Original Contributions
110Assessment of left ventricular diastolic function by radionuclide ventriculography in patients with chronic heart failure and reduced ejection fractionJan Naar, Filip Málek, Otto Lang, Otakar Bělohlávek, Jana Vránová, Tomáš Mráz, Eva Mandysová, Petr Neužil
114Dynamics of interleukin 6 levels in the patients with cardiogenic and septic shock and in a control group of patients with uncomplicated AMIJiří Pařenica, Jan Maláska, Jiří Jarkovský, Kateřina Helánová, Petr Jabandžiev, Jaroslav Michálek, Zuzana Veselková, Simona Littnerová, Lenka Kubková, Roman Gál, Pavel Ševčík, Monika Pávková Goldbergová, Jiří Litzman, Zdena Čermáková, Jindřich Špinar
Review
123MRI compatible cardiac pacemakers and implantable cardioverter defibrillatorsMichal Šnorek, Alan Bulava
128Oral infection and rheumatic diseasesLeona Procházková, Miroslav Souček
134Renal denervation for treatment of arterial hypertension – the unanswered questionsJitka Seidlerová, Jiří Koza, Ivo Bernat, Richard Rokyta, Vratislav Pechman, Jan Filipovský
139Therapy of Waldenström´s macroglobulinaemia in the year 2014Zdeněk Adam, Marta Krejčí, Luděk Pour, Eva Ševčíková
Guidelines
158The place of JAK2 inhibitors in the treatment of myelofibrosis. An amendment to the recommendations for diagnosis and treatment of Ph negative myeloproliferations of the Czech group for Ph- myeloproliferative disorders (CZEMP)Libor Červinek, Michael Doubek, Miroslav Penka, Jiří Schwarz (česká Pracovní Skupina Pro Ph Negativní Myeloproliferativní Onemocnění)
Case Report
171Catheter Related Septic Central Venous Thrombosis of the Superior Vena Cava and Right AtriumMiroslav Bambuch, Jiří Latta
Internal Medicine
2014 Issue 2
Most read in this issue- MRI compatible cardiac pacemakers and implantable cardioverter defibrillators
- Dynamics of interleukin 6 levels in the patients with cardiogenic and septic shock and in a control group of patients with uncomplicated AMI
- Catheter Related Septic Central Venous Thrombosis of the Superior Vena Cava and Right Atrium
- The place of JAK2 inhibitors in the treatment of myelofibrosis. An amendment to the recommendations for diagnosis and treatment of Ph negative myeloproliferations of the Czech group for Ph- myeloproliferative disorders (CZEMP)
Login#ADS_BOTTOM_SCRIPTS#Forgotten passwordEnter the email address that you registered with. We will send you instructions on how to set a new password.
- Career